Skip to main content
. 2024 May 3;23:88. doi: 10.1186/s12943-024-02005-y

Fig. 4.

Fig. 4

USPs regulate molecular targeted drug resistance. A USPs deubiquitinate key nuclear proteins, enhancing DNA damage repair and leading to resistance to PARP inhibitors. Inhibitors targeting USP7 improve the therapeutic efficacy of PARP inhibitors in treating cancer. B USPs are involved in imatinib (IM) resistance in chronic myeloid leukemia (CML) and gastrointestinal stromal tumors